Background: Heart failure (HF) is a condition with poor outcome, especially in advanced cases. Determination of B-type natriuretic peptide (BNP) levels is useful in the diagnosis of cardiac decompensation and has also been proving useful in the prognostic evaluation.
Objectives: To verify whether BNP levels are able to identify patients with a poorer outcome and whether it is an independent prognostic factor considering age, gender, cardiac and renal functions, as well as the cause of heart disease.
Background: Patients who require hospitalization because of decompensated HF represent a group of the most seriously ill individuals who evolve with high mortality and hospital readmission rates.
Objectives: We sought to evaluate the current natural course of HF by analyzing mortality and readmission rates in this new era of neurohormonal blockage.
Methods: We followed the progress of 263 patients with a mean EF of 27.
Objective: To verify if the determination of NT-proBNP values would help predict the prognosis in advanced heart failure (HF) patients.
Methods: One hundred and five subjects with average age of 52.4 years were evaluated, 66.